Page 319 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer
P. 319

Appendix Table C1.14. Treatment characteristics—changes in treatment patterns over time (continued)
 Author   Database   Treatment   1980-  1985-89   1990-94   1995-  2000-04   2005-  Statistical   Notes
 Year   84      99                     10       analysis
 PMID
 36
 Harlan    SEER   RP   11.0%      32.3%            P<0.001           Additional
 1995    RT   27.0%   29.7%                     (chi-square test)    information is
 7799048   Other   NR   NR                                           presented in
 (including, ADT   (1984)   (1991)                                   Figures 1-4 of
 or careful                                                          the paper
 observation                                                         (1984-91).
 with therapy
 reserved for
 clinical
 progression)
 Age-adjusted
 proportions for
 initial Tx (within
 4 mo of
 diagnosis)
 41
 Miller    SEER   EM/ADT               20.0%      P=0.042            Higher-risk
 a
 2006    RP              43.1%                  (overall chi-        patients were
 16912266   RT           36.9%                  square test for      those with
 [higher-risk]           (2001)                 2000-02)             poorly diff.
                                                                     tumors
                                                                     regardless of
                                                                     age or those
                                                                     with
                                                                     moderately
                                                                     diff. tumors
                                                                     aged <70 yr.
















 a  The study reported data for the period 2000-02, which fits entirely in one of our table’s 5 yr bins. We extracted data for the midpoint of the study period (i.e.,
 2001) along with the p-value from tests comparing the frequency of treatments across all 3 study years. Readers are referred to the full text of the paper for
 additional information.




 C-77
   314   315   316   317   318   319   320   321   322   323   324